PCRX
Pacira Biosciences
$25.16
−$0.72 (−2.78%)Sep 10, 2026
Key metrics
The numbers that frame PCRX today
- Market cap
- $1.00B
- P/E (TTM)
- 68.5
- EV / FCF
- 6.7
- Gross margin
- 79.2%
- EV / Sales
- 1.6
- ROIC
- 3.2%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $18.80
- 52wk High
- $27.66
Growth
Revenue and earnings trend for PCRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PCRX
Is Pacira Biosciences a good buy?
Yes. Pacira Biosciences has excellent quality, and it outweighs the weak momentum here. Growth looks excellent, which supports the long-term business case. We think Pacira Biosciences is selling at a low price.
What is the market capitalization of PCRX?
Pacira Biosciences's market capitalization is $1.00B.
What is the P/E ratio for PCRX stock?
Pacira Biosciences's current P/E ratio is 68.5.
What is the 52-week high for PCRX stock?
The 52-week high for Pacira Biosciences is $27.66. The current close of $25.16 is 9% below that high.
What is the 52-week low for PCRX stock?
The 52-week low for Pacira Biosciences is $18.80. The current close of $25.16 is 33.8% above that low.
Does PCRX stock pay dividends?
Pacira Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PCRX?
Pacira Biosciences's Debt / Equity ratio is 0.61.